Correction Notice To Press Release Regarding Dividend Amount

WASHINGTON, Sept. 25, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) announced today a correction to the previously announced quarterly cash dividend payable on its 5.00% Series B Mandatory Convertible Preferred Stock. As corrected, the Company will pay a quarterly cash dividend of $12.50 per share of its 5.00% Series B Mandatory Convertible Preferred Stock,... Read more

Clear Labs Granted EUA by FDA for SARS-CoV-2 Novel Descriptive Diagnostic

NGS-enabled platform tracks infection clusters for contact tracing and monitors emerging mutations, combining once separate aspects of screening and genomic surveillance SAN CARLOS, CALIF. (PRWEB) SEPTEMBER 24, 2020 Clear Labs, providers of the only fully automated and intelligent next-generation sequencing (NGS) in vitro diagnostic (IVD) platform, today announced that the U.S. Food and Drug Administration (FDA) has... Read more

Luminex Receives BARDA Award to Support 510(k) Filing for NxTAG Respiratory Pathogen Panel That Includes SARS-CoV-2

AUSTIN, Texas, Sept. 24, 2020 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that it has received a $5,389,813 award from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services, to conduct product development work and complete... Read more

New Liquid Chromatography-Mass Spectrometry Workstream Offers Comprehensive Solution for Toxicology

New Liquid Chromatography-Mass Spectrometry Workstream Offers Comprehensive Solution for Toxicology New Thermo Scientific Tox Explorer Collection provides instruments, columns and consumables with reliable and validated methods for reproducible results SAN JOSE, Calif., Sept. 24, 2020 /PRNewswire/ — Clinical research, forensic and anti-doping toxicology laboratories facing the challenges of analyzing increasing numbers of analytes in biological matrices,... Read more

Illumina to Webcast Upcoming Investor Conference Presentation

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast. Cowen’s Liquid Biopsy SummitThursday, September 24, 2020 at 9:30am Pacific Time The live webcasts can be accessed in the Investor Info section of Illumina’s web site under the “company” tab... Read more

Luminex Receives BARDA Award to Support Enhancement of COVID-19 Multiplex Antibody Test

AUSTIN, Texas, Sept. 23, 2020 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that it has received an award of $683,500 from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services, to support the enhancement of... Read more

Thermo Fisher Scientific Introduces Oncomine Clinical Research Grant Program to Support Oncology and Reproductive Health Studies

Thermo Fisher Scientific Introduces Oncomine Clinical Research Grant Program to Support Oncology and Reproductive Health Studies CARLSBAD, Calif., Sept. 23, 2020 /PRNewswire/ — Thermo Fisher Scientific today introduced the Oncomine Clinical Research Grant Program to support clinical research projects in oncology and reproductive health. The program aims to provide support for high-quality molecular profiling studies... Read more

BioTtechne Announces Commercial Release of New Co-detection Assays for Simultaneous Detection of RNA and Protein on the Same Sample

Expanding Bio-Techne’s lead in providing multi-omics research tools to co-detect RNA and protein targets MINNEAPOLIS, Sept. 22, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced the expansion of the Advanced Cell Diagnostics (ACD)-branded RNAscope™ technology with release of the new RNA-Protein Co-Detection Assays. The RNAscope technology is an advanced in situ hybridization (ISH) assay that enables... Read more

Bio-Techne Rebrands B-MoGen Biotechnologies as Part of the R&D Systems Product Portfolio

MINNEAPOLIS, Sept. 21, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced that the B-MoGen Biotechnologies portfolio of genome engineering services, GMP therapeutic manufacturing services, and its proprietary transposon-transposase gene transfer system, TcBuster™, will be rebranded as R&D Systems. As part of the rebranding, the B-MoGen Biotechnologies website will be retired. Service details and purchasing... Read more

PerkinElmer Launches Solus Listeria monocytogenes ELISA Assay for Testing Across Food and Environmental Samples

Solution Receives AOAC® PTM SM Certification WALTHAM, Mass. – September 21, 2020 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today launched the PerkinElmer Solus Listeria monocytogenes ELISA Assay. This new offering will help high throughput food processors and contract labs focus on L. mono testing for food and environmental... Read more